An Explorative Prospective Observational Study to Describe Morphokinetic De-selection Parameters in Human Embryos
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 06 May 2016
At a glance
- Drugs Menotropin (Primary)
- Indications Female infertility
- Focus Pharmacodynamics
- Sponsors Ferring Pharmaceuticals
- 03 May 2016 Planned End Date changed from 1 Mar 2016 to 1 Nov 2016.
- 03 May 2016 Planned primary completion date changed from 1 Jan 2016 to 1 Aug 2016.
- 03 May 2016 Status changed from recruiting to active, no longer recruiting.